All News
magAssist’s NyokAssist™️ granted Designation by the FDA as a Breakthrough Device
Recently, magAssist's NyokAssist™ Interventional Ventricular Assist Device (hereinafter referred to as NyokAssist™), has been granted designation as a breakthrough device by the U.S. Food and Drug Administration (FDA) in Breakthrough Device Program.
Six-month extension of the U.S.-China Science and Technology Cooperation Agreement: What different factions in the United States think
This week, the Agreement Between the United States and China on Cooperation in Science and Technology expired. The Biden administration, under strong pressure from both the pro and the opposite, decided to take a stopgap measure and extend the agreement for six months.
The China contagion that never was
Markets aren’t worried about China contagion – and you shouldn’t be, either.
Will NEUCA be taken over by the Chinese?
According to unofficial information from the authors, talks are underway about the acquisition of a controlling stake in Neuci by a consortium of Chinese companies, including Sinopharma.
The CSRC launched a series of policies tightening IPOs
2023年8月27日，在万众期待之下，证监会推出了一系列救市政策，包括降低印花税、IPO收紧、降低两融保证金、规范减持等多项内容。
The China Securities Regulatory Commission coordinates the balance of the primary and secondary markets and optimizes the regulatory arrangements for IPOs and refinancing
The China Securities Regulatory Commission (CSRC) announced on 27 August that the CSRC fully considers the current market situation, improves the counter-cyclical adjustment mechanism of the primary and secondary markets, and makes arrangements around reasonably grasping the rhythm of IPO and refinancing.
Pfizer Fights Claim It Fired Executive Who Raised Graft Concerns
Pfizer Inc. is fighting a lawsuit by a former employee who alleges he was fired after he raised concerns about the company paying tens of millions of dollars to government officials in China, where the drugmaker’s business practices have been under US review.
Curiox Biosystems Inc., Announces Initial Public Offering (IPO)
Curiox Biosystems Inc., a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, announced today the pricing of its initial public offering of 1,400,000 shares of its common stock at a price to the public of 13,000 won per share.
CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency
CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based immunotherapies for the treatment of various cancers, announces today that it signed a Memorandum of Understanding (MOU) with Hangzhou CNK Therapeutics Co., Ltd (CNK).
Biocytogen Announces Grand Opening of Waltham, MA Facility
Biocytogen Pharmaceuticals (HKEX: 02315; “Biocytogen”), a biotechnology company focused on the generation and validation of novel antibody-based therapeutics and specialized animal models for partners worldwide, today announces the grand opening of a new 37,000 sqft. facility in Waltham, MA for its US-based subsidiary, Biocytogen Boston Corporation.
